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INTRODUCTION
Steroid effects are classically mediated through intracellular receptor proteins, belonging to the nuclear receptor superfamily. Upon steroid binding, they dimerize, translocate to the nucleus and act as ligand-activated transcription factors, modulating steroid-dependent genes (Kumar and Tindall, 1998) . In recent years, however, an alternative mode of steroid action has been revealed integrating rapid actions, initiated at the membrane level and leading to a multitude of cellular modifications, such as rapid ion movement through the plasma membrane, secretion modification and initiation of signaling cascades (Hammes and Levin, 2007) . The later lead ultimately to transcriptional activation, distinct from the one initiated by nuclear receptors (Notas et al., 2010) . Rapid plasma membrane-related actions, although described as early as 1942 (Seyle, 1942) , became a field of intense research only in the last decade. The nature of membrane steroid binding sites has not been unanimously accepted. Non-mutually exclusive possibilities include: (i) membrane anchoring of intracellular receptors through post-translational modifications, acting independently or in association with growth factor receptors (Marino and Ascenzi, 2006) ; (ii) truncated or alternative spliced steroid receptors (Wang et al., 2006) ; (iii) novel receptor proteins (Zhu et al., 2003) . Indeed, a number of receptors have been reported, belonging mainly to the GPCR family, to mediate some of the membrane-initiated steroid effects. However, there is an extensive discussion whether these receptors are true steroid receptors or co-receptor proteins (Levin, 2009 ).
Even if the identity of androgen membrane receptor(s) remains a field of extended exploration (Kampa et al., 2008) , the repertoire of their membrane effects is widely accepted to lead to actin cytoskeleton modifications and specific genes' transcription, independently from nuclear androgen receptor action (Notas et al., 2010) . Membrane androgen binding sites have been
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reported in a number of normal or malignant tissues and lesions. In particular, androgen sites have been detected in T-lymphocytes (Benten et al., 1999) , spermocytes and sperm (Walker, 2003) , as well as in breast (Pelekanou et al., 2007) , prostate and colon cancer (Gu et al., 2009) . In both breast and prostate, membrane-acting androgen have been reported to induce tumor regression, alone (Hatzoglou et al., 2005) or in combination with cytoskeletal acting drugs (Kampa et al., 2006) , suggesting a potential therapeutic role of membrane androgen agonists in breast and prostate cancer. However, until recently, no specific agonists (except for large molecule-conjugated androgen) have been described.
Polyphenol-rich foods and beverages have been implicated in the prevention of a number of chronic conditions, including cardiovascular diseases and cancer. Nevertheless, although a number of epidemiological and intervention studies demonstrate this beneficial effect, experimental data dealing with their mode of action are divergent. Indeed, polyphenols are considered to enter the cell (after a possible biotransformation) and to modify a number of cellular responses, including signaling molecules, enzymes, and/or transcription factors, leading ultimately to modification of the cell fate, towards survival or apoptosis (see Kampa et al., 2002, for a review). Interestingly, a recent report suggests also a potential membrane-initiated action of catechin analogs (Bastianetto et al., 2009) , interacting with PKC isoforms, a finding compatible with our previous results on signaling cascades initiated by membrane-acting testosterone conjugates (Papakonstanti et al., 2003) . In addition, we have previously reported that the flavanols catechin and epicatechin, and their dimers B5 and especially B2 are in vitro agonists of membrane androgen sites, activating focal adhesion kinase and PI3-K, modifying further actin polymerization, leading mammary adenocarcinoma cells to apoptosis (Nifli et al., 2005) . In the present work, we initially assayed natural and modified proanthocyanidin derivatives B1-B4 on This article has not been copyedited and formatted. The final version may differ from this version. prepared and subjected to DCC treatment (dextran 0.05mg/ml and charcoal 50mg/ml) for 30 min, in order to remove any potential contamination with free testosterone (Hatzoglou et al., 2005) . We assayed routinely culture media for the presence of free testosterone with a specific radioimmunoassay method with negative results. Cell growth was assayed by the tetrazolium salt assay.
Proanthocyanidin isolation and synthesis of derivatives
Proanthocyanidins were all obtained from EtOAc grape seeds extracts (Vitis vinifera, Vitaceae) on which Centrifugal Partition Chromatography (CPC) in hexane-ethyl acetate-ethanol-water
(1:8:2:7; v/v/v/v) was applied, as described previously (Delaunay et al., 2002) . This quantitative process allowed us to separate seven blocks in the ascending mode. Isolation of every proanthocyanidin was then realized by preparative reverse C18 High Performance Liquid Chromatography (Prep-HPLC) of each blocks, using a 0-100% methanol-water gradient. Eleven proanthocyanidins were thus isolated as pure compounds and fully characterized. Their identification was ascertained by two complementary methods: 1) by comparing 2D long range NMR spectra (Gradient Accelerated Spectroscopy-HMBC (Bax and Summers, 1986) ) of This article has not been copyedited and formatted. The final version may differ from this version.
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peracetylated proanthocyanidins with those of references (Balas et al., 1995) , to establish their gross structure and 2) by comparing chromatographic behaviour of the adducts formed from each one upon acid hydrolysis in the presence of excess phloroglucinol (Kennedy and Jones, 2001) , with those issued from reference samples, after co-injection on an analytical HPLC system, coupled to PDA-detection online with an electrospray ionization mass spectrometer, to confirm the nature (catechin or épicatéchine series) of each moiety and to ascertain the type of the inter- by centrifugation at 45,000g for 1 hour, then acidified with one volume of 50 mM glycine pH 3 for 3 min, in order to dissociate any intracellular loosely bound or adsorbed androgen receptor (Hatzoglou et al., 1994) , and resuspended in ten volumes Tris-HCl buffer. After an additional centrifugation at 45,000g for 1 hour, protein concentration was measured by the method of Bradford.
Binding experiments were performed in a final volume of 0.1 ml, containing DU145 cell membranes (2 mg/ml) and 5nM of [ 
Actin cytoskeleton staining and visualization
Cells were grown on poly-L-lysine-coated 8 well chamber slides. After incubation with the different agents for 10 min, actin network were visualized by direct fluorescence microscopy.
Cells were fixed with 4% paraformaldehyde in PBS for 10 minutes at room temperature, permeabilized with 0.5% Triton X-100 for 15 min and incubated in blocking buffer (2% BSA in PBS). Actin cytoskeleton was visualized with rhodamine-phalloidin staining (1:400 in PBS containing 0.2% BSA) for 45 min. Specimens were analyzed in a Leica SP confocal microscope.
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Signaling molecule identification
Testosterone-BSA-or polyphenol-treated cells (10 -7 M, for the indicated time-periods), as well as untreated (control) cells were washed three times with ice-cold PBS and suspended in cold lysis buffer containing 1% Nonidet P-40, 20 mM Tris pH 7.4 and 137 mM NaCl, supplemented with protease and phosphatase inhibitors. Cleared lysates were preadsorbed with protein A-Sepharose for 1 h at 4 °C, centrifuged and the supernatants (equal amounts of protein) were subjected to immunoprecipitation using the indicated antibodies and the protein A-Sepharose beads.
For immunoblot analysis, the cell lysates or the immunoprecipitates were suspended in Laemmli's sample buffer and separated by SDS-PAGE. Proteins were transferred onto nitrocellulose membrane, and blocked with 5% nonfat dry milk in TBS-T (20 mM Tris pH 7.6, 137 mM NaCl, 0.05% Tween-20) for 1h at room temperature. Antibody solutions (in TBS-T containing 5% nonfat dry milk) were added overnight at 4 °C (first antibody) and for 1h (second horseradish peroxidase-coupled antibody). Blots were developed using the ECL system and the band intensities were quantitated by PC-based image analysis (Image Analysis Inc., Ontario, Canada). Anti-phosphotyrosine (PY20) as well as polyclonal antibody for FAK (rabbit) were from Santa Cruz Biotechnology Inc. Rabbit polyclonal anti-PI-3 kinase(p85) antibody was purchased from Upstate Biotechnology Inc.
In vivo experiments with nude mice
Male BalbC -/-nude mice (10 week old) were from Harlan (Italy). Animals were injected subcutaneously in the back with 5x10 6 DU-145 cells diluted in Matrigel ® (Sigma) in a total volume of 0.1 ml. After 2 weeks, macroscopic tumors were developed. Then, vehicle (PBS), testosterone-BSA (8 mg/kg), B2 (0.08 mg/kg) or oleylated-B2 (0.16 mg/kg), in order to achieve This article has not been copyedited and formatted. The final version may differ from this version.
a calculated concentration of 10 -7
M of either substance in body fluids. The choice of this concentration derived from in vitro experiments described above. Substances were diluted in PBS and injected intraperitoneally 3 times per week, in a total volume of 0.5 ml. Tumor size was measured with a vernier weekly and its weight was calculated by the formula 1/2a x b 2 where 'a' is the long diameter and 'b' is the short diameter of the tumor (both in cm) (Wang et al., 2003) .
The animals were sacrificed at the indicated time (4 weeks after the initiation of therapy).
Tumors were excised, measured, fixed in formalin and analyzed by a pathologist. Liver and testes were analyzed by the same pathologist blindly for changes indicative of testosterone or OPC action. The inhibitory rate (IR) of tumor growth was calculated according to the following equation 1 (Zhou et al., 2005) :
where C is control group, T is treated group, W 1 is the tumor weight before treatment, W 0 is the weight after treatment. The protocol for animal treatment was approved by the School of Medicine Research and Ethics Committee.
Histological staining
Serial sections of tumors (3μ thick) were cut from each paraffin block (tumors, liver and testes) and layered on negatively charged (SuperFrost Plus) slides (Kindler O GmbH, Freiburg, Germany). One slide was stained with hematoxylin-eosin and observed directly. The labeling streptavidin-biotin method, using the SuperSensitive Biotin-Streptavidin Immunodetection System (QA200-OX, Biogenex, San Ramon, CA) according to the manufacturer's instructions, was used to immunostain sections, for mitotic activity with the mouse anti-human monoclonal This article has not been copyedited and formatted. The final version may differ from this version. 
OPCs B1-B4 dispose distinct inhibitory properties in each cell line: In LnCaP cells, the effect of all OPCs was minimal, decreasing cell growth by 7-13%. The calculated IC 50 s for OPCs ranged from 0.5 to 30.4 nM (with B3=B4>B2>>B1), while for testosterone-BSA was 0.7 nM. In contrast, in the androgen-insensitive DU-145 cell line, OPCs were more potent than in LNCaP cells, decreasing cell growth from 12-31%. IC 50 s ranged from 0.6-74 nM, with B2>>B3=B4>B1
( Table 1 ). In addition, the inhibitory effect of testosterone-BSA in DU-145 cells was more pronounced (~40%) with an IC 50 similar to the one observed in LnCaP cells (0.8 nM).
Implication of galloylation in oligomeric flavanols activity modification
Previous data showed that galloyl-esters of monomeric catechins exert a substantial effect on cell survival and metabolism (see Butt and Sultan, 2009, bears a carboxy-methyl-BSA substitution at position 3 that could account for the observed differences in B2 and testosterone-BSA IC 50 s. However, according to our previous results the carboxymethyl-oxime group did not originate the observed actions of testosterone-BSA (Kampa et al., 2002; Papakonstanti et al., 2003) . In an attempt to improve B2 activity and bioavailability, we synthesized oleic acid ester derivatives. The dioleylated B2 derivative exerted a very potent inhibitory effect on cell growth in both LnCaP and especially in DU-145 cells, with an IC 50 similar to that of testosterone BSA (Table 1) . We have therefore focused at this B2-diester, trying to investigate its mode of action, both in vitro and in vivo. Similar, albeit less pronounced effects were also detected with the corresponding oleyl ester derivative of B3 dimer (Table 1) .
Interaction of oleylated oligomeric flavanols with membrane androgen sites and actin cytoskeleton
Previous data indicate that B2 competes for binding on membrane androgen sites and induces changes similar to that of testosterone on actin cytoskeleton, through activation of the same This article has not been copyedited and formatted. The final version may differ from this version. Figure 3) , both B2
and oleylated B2 induced a peripheral actin redistribution, as obtained with testosterone-BSA ( Figure 3B ). These data suggest that oleylated B2 might trigger similar changes as testosterone-BSA and non-oleylated B2.
Effect of oleylated or native proanthocyanidins on the regression of prostate tumor xenografts in BALBc -/-mice
The in vitro results so far suggest that both B2 and its oleylated conjugate exert similar effects to testosterone-BSA, acting on membrane androgen sites. We have further verified these actions in vivo. BALBc -/-mice, were inoculated with DU145 cells. The reasons of using this cell line were:
(1) it contains no functional intracellular androgen receptors, permitting the deciphering of the This article has not been copyedited and formatted. The final version may differ from this version. Figure 4A show that testosterone-BSA decreased tumor size by ~40%, in accord to our previously published data (Hatzoglou et al., 2005; Kampa et al., 2006) ; B2 decreased tumor size by ~30%, while oleylated-B2 had the maximal effect, decreasing tumor size by ~50%. Expressing results as the inhibitory rate of each substance (Zhou et al., 2005 ) the early and sustained effect of oleylated-B2 becomes obvious ( Figure 4B ). This is accompanied by a change in cell morphology of the tumors ( Figure 4C ); tumor cells of treated animals were smaller, presenting an increased of view. In addition, a more refined identification of cells in the cell cycle was effected by means of the MIB1 antibody, which is raised against the nuclear antigen Ki67.The histologic analysis of untreated tumors showed mitoses predominating at the periphery of the tumors namely their "growing edge" verifying previous data in the same strain, using testosterone-BSA conjugates (Kampa et al., 2006) . The evaluation of mitotic index evidenced a decrease of proliferative cells in testosterone-and oleylated B2-treated tumor cells, confirming our in vitro data.
Oleylated OPC does not exert toxicity or androgenic actions
Although previous data suggest that testosterone-BSA does not release free testosterone in body fluids (Hatzoglou et al., 2005) , in the present work we have assayed, using a specific testosterone assay, its concentrations in the plasma of treated mice. No significant changes between control and testosterone-treated mice were observed (not shown). In order to access the possible proandrogenic effect of B2, we have analyzed the volume and histology of testes. Testicular volume remained unaltered in treated animals, as compared to control (not shown), while histology of the testes did not show any modification of spermatozoide production and maturation (Supplemental Figure 4 ).
In addition, as the liver is the main organ of detoxification, we have assayed liver aminotransferases (ALT, AST) through specific assays, in serum. No modification of enzyme levels was observed (not shown). In addition, liver or testes morphology did not differ in treated animals, as compared to the control (Supplemental Figure 3) . We have therefore concluded that neither testosterone-BSA nor oleylated B2 exert any significant toxicity in treated mice, after one month treatment.
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DISCUSSION
Prostate cancer is the commonest diagnosed neoplastic disease in Western male populations and the second leading cause of cancer-related deaths. The natural history of the disease usually starts as an androgen-dependent tumor and evolves to androgen insensitivity. Current treatment protocols suggest surgical ablation of the tumor, followed by anti-androgen and/or chemotherapy, though reoccurrence is not excluded and, especially at the advanced stages of the disease, the outcome is poor. Therefore, alternative therapeutic approaches are investigated.
Our previous data indicate that human prostate cancer specimens express preferentially membrane androgen binding sites, as compared to adenomas or non-tumorous tissue, which correlate with the severity of the disease, expressed by the Gleason's score . In addition, membrane androgen receptor agonists (in the form of testosterone-protein conjugates), alone (Hatzoglou et al., 2005) , or in association with taxane-based drugs (Kampa et al., 2006) , induce the regression of prostate cancer xenografts (both hormone sensitive or resistant), proposed as an alternative therapeutic strategy. However, steroid-protein conjugates are difficult to manage, necessitating intravenous administration. In the search of potential micromolecular agonists of membrane androgen sites, we have previously reported that oligomeric proanthocyanidins (OPC) of the B series, could interact with these sites (Nifli et al., 2005) . Here, we analyzed natural OPC B-series and provide evidence about a specific effect of a novel, semi-synthetic, oleylated derivative.
Although estrogenic actions have been studied extensively for a number of polyphenols (see Kampa et al., 2007 , for an extensive review), their androgenic activity is rather rarely assayed.
Previous data have shown that catechins may interact with androgen receptors in prostate cancer
cell lines (Kampa et al., 2000) , while they may modulate androgen secretion (Liao, 2001 ) and the expression of androgen receptors (Ren et al., 2000) . A recent report further suggests also a potential membrane-initiated action of catechin analogs (Bastianetto et al., 2009 ), rapidly modifying PKC isoforms. Our previous results (Nifli et al., 2005) and data presented here suggest that indeed catechins interact with membrane androgen sites. In addition, our data support that OPC derivatives (and especially B2 which has the highest activity) present a spatial conformation similar to that of testosterone, providing a molecular hint of their interaction with androgen sites and androgen-like actions. In addition, we report that OPC derivatives compete for binding, induce signaling molecule changes, modify actin cytoskeleton, decrease cell growth and reduce tumor size in mice, in a way similar to that of conjugated testosterone. In that respect we propose them as agonists of membrane androgen sites, an element which might be of a potential therapeutic importance.
The nature of membrane androgen sites has not been elucidated until now. Their characterization resides to pharmacological elements, namely the binding of androgen to membranes (Benten et al., 1999) , the triggering of specific signaling cascades (Pelekanou et al., 2010) , the modification of intracellular elements (Papakonstanti et al., 2003) , the movements of ions through plasma membrane (see Kaarbo et al., 2007 , for a recent review) and the transcriptional regulation of a number of genes, different from those initiated from unconjugated testosterone (Notas et al., 2010) . There are evidences that they might be G-coupled protein receptors (Kaarbo et al., 2007) , Not all studied OPC derivatives exert a specific membrane-initiated androgenic effect. Focusing on DU-145 cells (which are androgen insensitive) and the molecular structures presented in Figure 1 , it becomes obvious that some specific molecular elements are needed for such an effect: (i) the beta configuration of the 4-8-link between the two flavanol moieties, (ii) the "2,3-cis" configuration (epicatechin 2R,3R-series) of the monomers (especially the alpha configuration of the hydroxyl group at position 3F) and (iii) the presence of a free hydroxyl group at this 3F position. In addition, oleylation confers an increased affinity to the OPC molecule. It is not clear why this latter modification increases the potency of OPC molecules.
One possibility might be that oleylation confers to the molecule a structure similar to that of conjugated testosterone, but more certainly, this is related to the increased lipophilicity of the resulting molecule, permitting its better incorporation into the plasma membrane and a better interaction with growth factor receptors (an element described for membrane-acting androgen, see Kampa et al., 2008 , for a review), or with membrane anchored, conventional (Marino and Ascenzi, 2006) or not, androgen sites. Indeed, the latter hypothesis has been recently explored in the case of estrogen receptors, where an alternative form of ERα (ERα36) has been proposed to initiate the membrane effects of the hormone . J P E T # 1 7 7 2 4 6 P a g e 2 7
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Marino M and Ascenzi P ( This article has not been copyedited and formatted. The final version may differ from this version. LEGENDS FOR FIGURES Figure 1 Chemical structures of the substances used in the study magnifications, stained with hematoxylin and eosin and MIB1 antibody, staining Ki67.
Apoptotic cells are denoted by arrows, in high magnification sections.
This article has not been copyedited and formatted. The final version may differ from this version. Time course of the phosphorylation state of PI3K and FAK, after incubation of cells with 10 -7 M testosterone-BSA or B2 for the indicated time periods (5, 15, 30 min). DU-145 cells were lysed and the phosphorylated PI3K and FAK were assayed by electrophoresis and immunoblotting as described in Materials and methods. Data Mean±SEM of three different experiments) are presented as compared to the corresponding control, set as one. Liver and testes have been withdrawn from treated mice (after 4 weeks treatment with oleylated B2, testosterone-BSA or vehicle), fixed in formol, and sections were stained with hematoxylin-eosin and examined. As shown, no morphological changes were apparent. Testes did not show any androgenic effect (increased spermatogenesis).
